Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Delisting Looms As More US-Listed China Companies Seek To Move Closer Home
More Options Than US Listing
Aug 23 2022
•
By
Brian Yang
MORE CHINESE FIRMS TO POTENTIALLY DELIST FROM THE US MARKET FOLLLOWING FIVE SOES • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Financing
More from Business